Antibody Therapeutics provides a focused look at the preclinical and clinical development of antibody-based drug products. At this year's meeting, you will hear updates of preclinical and clinical stage programs, review the current state of the
antibody therapeutics market and learn about trends in IP law that could impact your development candidates.
antibody therapeutics market and learn about trends in IP law that could impact your development candidates.
